Daiichi Sankyo Begins Shipping Amgen’s Trastuzumab Biosimilar In Japan
Partnership inked between the Japanese and US players in July 2016 results in Daiichi Sankyo launching its first biosimilar product.
Partnership inked between the Japanese and US players in July 2016 results in Daiichi Sankyo launching its first biosimilar product.